Question: The acellular pertussis vaccine uses a biotechnology based immunization strategy that
The acellular pertussis vaccine uses a biotechnology-based immunization strategy that has been adapted for this approved vaccine. What advantages does the biotechnology-based vaccine have over a conventional vaccine? What disadvantages, if any?
Relevant QuestionsDefine the differences between immediate and delayed-type hypersensitivity in terms of immune effectors, target tissues, antigens, and clinical outcome. Describe the complement system. Is the order of protein interactions important? Why or why not? Identify the components of the mannose-binding lectin pathway for complement activation. Identify the components of the ...Describe the potential problems that would arise if a person had an acquired inability to phagocytose pathogens. Could the person survive in a normal environment such as a college campus? What defects in the phagocyte might ...Polymorphism implies that each different MHC protein binds a different peptide motif. For the MHC class I polymorphisms, how many different MHC proteins are expressed in an individual? By the entire human population? What would be the result of activation of all T cells that contact antigen? How does the multiple signal mechanism prevent this from happening?
Post your question